Ambient Air Pollution and the Progression of Atherosclerosis in Adults

Nino Künzli, Michael Jerrett, Raquel Garcia-Esteban et al. · 2010

Read Ambient Air Pollution and the Progression of Atherosclerosis in Adults by Nino Künzli, Michael Jerrett, Raquel Garcia-Esteban et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009096.txt.

Introduction

Nino Künzli and co-authors followed adults' neck arteries to see whether dirty air thickens them, in PLOS ONE in 2010. Atherosclerosis is the slow clogging of arteries behind heart attacks and strokes. Earlier snapshot studies tied air pollution to thicker artery walls. A snapshot cannot show the disease actually progressing, though.

The team measured the carotid artery wall over time in adults. Wall thickness is a standard marker of subclinical atherosclerosis. People breathing worse outdoor air showed faster thickening. Following progression, not just presence, strengthens the case against polluted air.

Catalog record

CREATORNino Künzli, Michael Jerrett, Raquel Garcia-Esteban et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009096

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Ambient Air Pollution and the Progression of Atherosclerosis in Adults Authors: Nino Künzli, Michael Jerrett, Raquel Garcia-Esteban, Xavier Basagaña, Bernardo Beckermann, Frank Gilliland, Merce Medina, John Peters, Howard N. Hodis, Wendy J. Mack Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0009096 ABSTRACT Cross-sectional studies suggest an association between exposure to ambient air pollution and atherosclerosis. We investigated the association between outdoor air quality and progression of subclinical atherosclerosis (common carotid artery intima-media thickness, CIMT). We examined data from five double-blind randomized trials that assessed effects of various treatments on the change in CIMT. The trials were conducted in the Los Angeles area. Spatial models and land-use data were used to estimate the home outdoor mean concentration of particulate matter up to 2.5 micrometer in diameter (PM2.5), and to classify residence by proximity to traffic-related pollution (within 100 m of highways). PM2.5 and traffic proximity were positively associated with CIMT progression. Adjusted coefficients were larger than crude associations, not sensitive to modelling specifications, and statistically significant for highway proximity while of borderline significance for PM2.5 (P = 0.08). Annual CIMT progression among those living within 100 m of a highway was accelerated (5.5 micrometers/yr [95%CI: 0.13–10.79; p = 0.04]) or more than twice the population mean progression. For PM2.5, coefficients were positive as well, reaching statistical significance in the socially disadvantaged; in subjects reporting lipid lowering treatment at baseline; among participants receiving on-trial treatments; and among the pool of four out of the five trials. Consistent with cross-sectional findings and animal studies, this is the first study to report an association between exposure to air pollution and the progression of atherosclerosis – indicated with CIMT change – in humans. Ostensibly, our results suggest that air pollution may contribute to the acceleration of cardiovascular disease development – the main causes of morbidity and mortality in many countries. However, the heterogeneity of the volunteering populations across the five trials, the limited sample size within trials and other relevant subgroups, and the fact that some key findings reached statistical significance in subgroups rather than the sample precludes generalizations to the general population. INTRODUCTION Cardiovascular disease (CVD) is the most important cause of morbidity and mortality in the developed world, and atherosclerosis is the central underlying pathology [1] . Atherogenesis is a life-long process involving a range of mechanisms including lipid peroxidation and inflammation affecting the vascular wall. The clinically most relevant results of this pathology are myocardial infarction and stroke. Evidence for acute cardiovascular effects of air pollution has substantially increased in recent years; most experts agree that ambient particulate matter plays a role in triggering cardiovascular events among those with predisposing cardiovascular pathologies [2] , [3] . Experimental studies indicate a mechanistic role of air pollution in various acute cardiovascular processes including ischemia, endothelial dysfunction, activation of the fibrinolytic system and possibly plaque destabilization [2] , [4] . Far less research has tested the question whether ambient air pollution also contributes to the development of chronic pathologies, such as atherosclerosis, that predispose to acute cardiovascular disease. Animal studies conducted in rabbits, rats or mice with urban particulate matter instillation and inhalation experiments, indicate more rapid progression of atherosclerosis among animals exposed to urban particulate matter (PM) compared to filtered air [4] , [5] , [6] , [7] . A few cross-sectional studies observed significant associations between ambient PM or other markers of air pollution and the degree of atherosclerosis, measured with carotid artery intima-media thickness (CIMT) [8] , and both coronary and aortic calcifications [9] , [10] . To our knowledge, no study has investigated the impact of ambient air pollution on the progression of atherosclerosis in humans. Herein we used longitudinal data available from five randomized controlled trials to investigate whether chronic exposures to ambient air pollutants contribute to a faster progression rate of atherosclerosis in humans. We have previously reported a cross-sectional analysis of baseline CIMT from two of the five trials in the current study and observed a significant cross-sectional association between CIMT levels at baseline and assigned home outdoor levels of ambient PM2.5 [8] . We added longitudinal data from three additional trials that have completed two to three years of average follow-up [11] , [12] , [13] , [14] . METHODS This study used data from 5 pre-existing clinical trials, all of which are registered in ClinicalTrials.gov. (a) the B-Vitamin Atherosclerosis Intervention Trial (BVAIT; NCT 00114400 [ http://clinicaltrials.gov/ct2/show/NCT00114400 ]) [14] ; (b) the Vitamin E Atherosclerosis Prevention Study (VEAPS; NCT 00114387 [ http://clinicaltrials.gov/ct2/show/NCT00114387 ]) [15] ; (c) the Estrogen in the Prevention of Atherosclerosis Trial (EPAT; NCT 00115024 [ http://clinicaltrials.gov/ct2/show/NCT00115024 ]) [12] ; (d) the Troglitazone Atherosclerosis Regression Trial (TART [NCT 00116545; http://clinicaltrials.gov/ct2/show/NCT00116545 ]) [11] ; and (e) the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial (WELL-HART; NCT 00000559 [ http://clinicaltrials.gov/ct2/show/NCT00000559 ]) [13] . Table 1 summarizes the main characteristics of these trials and more details are given elsewhere [11] , [12] , [13] , [14] , [15] . (For exclusion criteria of each trial, see supplemental material, Table S2 ). All trials were conducted with adult volunteers. Inclusion criteria differed for each trial according to the primary hypothesis and the intervention of interest, namely testing the anti-atherogenic property of hormone replacement therapy [12] , [13] , vitamin supplementation [14] , [15] , and a diabetes treatment [11] . All clinical trials used in these analyses were approved by the institutional review board of the University of Southern California (USC). (CVD = cardiovascular diseases; LDL = low density lipids). For exclusion criteria: see Table S2 in the online supplement. For our study, the main outcome of interest is the change over time in the carotid artery intima-media thickness (CIMT). Repeated measurements of CIMT are a well-established non-invasive method to test the effect of interventions on atherosclerosis. In all trials, high-resolution far-wall B-mode ultrasound images of the right common carotid artery (CCA) to measure far wall CIMT were obtained at baseline prior to randomization to treatment, and every 6 months thereafter for the duration of the trials, using the same ultrasound hardware and software and ultrasonographers during the full follow-up. Details of this highly-reproducible method are published [15] , [16] , [17] . Blood pressure, height and weight were measured using standard procedures. The baseline questionnaires included an assessment of all major cardiovascular disease risk factors and potential confounding variables. The current residential address was available for each subject. Fasting blood samples were drawn for lipid measurements. Data used in our analyses were collected uniformly with the same instruments in each trial. We used two main markers of exposure to ambient air pollution to assign long-term residential exposure to each subject, namely the modeled average home outdoor level of PM2.5 and the distance of the residence from traffic corridors, a widely used marker of exposure to unmeasured traffic-related pollutant concentrations [18] . TABLE: Description of the B-Vitamin Atherosclerosis Intervention Trial (BVAIT), the Vitamin E Atherosclerosis Prevention Study (VEAPS), the Estrogen in the Prevention of Atherosclerosis Trial (EPAT), the Troglitazone Atherosclerosis Regression Trial (TART), and the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial (WELL-HART) used in this analyses. Characteristic BVAIT VEAPS EPAT TART WELLHART Year (start / end of trial) 2001 / 2006 1996 / 2000 1994 / 1998 1997 / 2000

Read the complete text